09 April 2010

First Generic Versions of Cozaar and Hyzaar Approved

Drugs to treat high blood pressure


This article has not necessarily been edited by Health24.

THURSDAY, April 8 (HealthDay News) -- The first generic versions of two drugs to treat high blood pressure, Cozaar (losartan potassium) and Hyzaar (losartan potassium and hydrochlorothiazide), have been approved by the U.S. Food and Drug Administration.

The generic versions will carry the same label warnings that they should not be used by pregnant women during their second or third trimesters, the agency said in a news release.

The brand-name versions of both drugs are manufactured by Merck & Co. Licenses to produce generics of one or both medications were granted to a number of firms, including Teva Pharmaceuticals, Mylan Pharmaceuticals, Roxane Laboratories and Torrent Pharmaceuticals, the FDA said.

More information

The FDA has more about generic drugs.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Hypertension expert

Dr Jacomien de Villiers qualified as a specialist physician at the University of Pretoria in 1995. She worked at various clinics at the Department of Internal Medicine, Steve Biko Hospital, these include General Internal Medicine, Hypertension, Diabetes and Cardiology. She has run a private practice since 2001, as well as a consultant post at the Endocrine Clinic of Steve Biko Hospital.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules